Abstract Dyslipidemia is a common metabolic disorder around the world, with a higher incidence in the population of childbearing age and those experiencing infertility
9,10 Additionally, GLP-1 RAs suppress glucagon secretion from the -cells in the pancreas, leading to decreased blood glucose levels
Role of GLP-1 Agonists and SGLT-2 on Diabetes and Kidney Disease Post Liver Transplant The emergence of Glucagon-like peptide-1 receptor (GLP-1) agonists and Sodium-glucose cotransporter-2 (SGLT-2) inhibitors as glucose-lowering therapies has opened new therapeutic avenues for managing patients with diabetic kidney disease
While the specific amount needed varies by individual and climate, most adults benefit from drinking approximately two liters of fluids daily, adjusting for activity level and environmental conditions
N-acetyl cysteine protects the liver and kidneys and improves detoxification pathways, in addition to having anti-inflammatory effects